Mammography vendor Loradhas made advances in retrofitting its digital breast biopsy technologyto the StereoLoc upright needle biopsy system, according to presidentHal Kirshner. Lorad, of Danbury, CT, will display a version ofits DSM (digital spot
Mammography vendor Loradhas made advances in retrofitting its digital breast biopsy technologyto the StereoLoc upright needle biopsy system, according to presidentHal Kirshner. Lorad, of Danbury, CT, will display a version ofits DSM (digital spot mammography) device that has been adaptedto work with the StereoLoc biopsy guide on the M-III mammographyunit.
The adaptation will enable Lorad users to conduct digitallyguided needle biopsies with patients in the upright position.Using the DSM/StereoLoc/M-III combination will give mammographersmore flexibility in conducting breast biopsy procedures, Kirshnersaid. The combination also gives mammographers the advantage ofusing the motor-driven DSM system.
Lorad will also display the latest work on its full-breastdigital mammography system. The company will once again show awork-in-progress prototype in its exhibit booth, and will displayboth hard- and soft-copy images acquired with the system thatshow its penetration of dense breast tissue.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Stroke MRI Study Assesses Impact of Motion Artifacts Upon AI and Radiologist Lesion Detection
July 16th 2025Noting a 7.4 percent incidence of motion artifacts on brain MRI scans for suspected stroke patients, the authors of a new study found that motion artifacts can reduce radiologist and AI accuracy for detecting hemorrhagic lesions.